Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot two-step method using Iron(II) phthalocyanine for high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability.
Novel synthesis route for Bilastine avoids toxic reagents. High yield, cost-effective manufacturing for pharmaceutical supply chains.
Patent CN110938028B details a cost-effective, three-step synthesis of high-purity (1R)-5-bromo-2,3-dihydro-1-methyl-1H-isoindole, optimizing supply chain stability for quinolone antibiotics.
Novel patent CN104177331A offers high-purity Bilastine intermediate synthesis with reduced toxicity and improved yield for pharmaceutical manufacturing.
Patent CN104817541A reveals a high-yield synthetic route for AZD9291 intermediates. This report analyzes cost reduction in pharmaceutical manufacturing and supply chain reliability for global buyers.
Patent CN115110104A details a green electrochemical route for dichloroaryl ketones, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Novel patent CN105085395B improves bedaquiline intermediate yield and purity significantly reducing manufacturing costs and enhancing supply chain reliability for global pharmaceutical partners.
Novel Selectfluor-mediated method for alpha-acyloxy thioethers. High yield, green chemistry, scalable process for pharmaceutical intermediates manufacturing.
Novel four-step synthesis of Sarpyridan using DMF and ammonium iodide. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Patent CN114605308A details a scalable synthesis of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using dihalo-acyl chloride cyclization, offering significant cost and safety advantages.
Patent CN105209435A reveals novel synthesis routes for pyridine compounds offering supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110746393A reveals a metal-free synthesis of 3-methylthio benzofurans using DMSO and SOCl2, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102718695B reveals a mild, high-yield route for aza-bicyclo[3.3.0]octane derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Lewis acid catalyzed synthesis offers high purity trans-isomer selectivity for pharmaceutical intermediate manufacturing supply chains and significant cost efficiency.
Novel alkaline crystallization method reduces Impurity A below 0.10% ensuring ICH Q3a compliance and supply chain stability for cardiac imaging agents globally.
Advanced synthesis of Regorafenib intermediate using inorganic bases. Safe, scalable, high-yield process for pharmaceutical supply chains.
Patent CN101984066A reveals a high-yield biological method for L-phenylalanine production, reducing acetate inhibition and offering significant cost advantages for reliable amino acid suppliers.
Patent CN112175034B reveals a novel one-pot synthesis for 17 alpha-hydroxyprogesterone with >94% yield. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN113816913B reveals improved oxazepam intermediate synthesis with reduced waste and enhanced safety for reliable pharmaceutical intermediates supply chains.
Novel convergent synthesis of racemization hanfangchin A offers cost reduction and scalable production for pharmaceutical intermediates supply chain.